Doxycycline Dosing for Soft Tissue Skin Infections
For adults with soft tissue skin infections, doxycycline should be dosed at 100 mg orally twice daily for 5-10 days, depending on clinical response. 1
Dosing Regimen
Standard Adult Dosing
- 100 mg orally twice daily 2, 1, 2, 1, 3
- Duration: 5-10 days (typically 7 days) 1
- Treatment should be extended if infection has not improved within 5 days 1
Pediatric Dosing (>8 years old)
- Not recommended for children under 8 years due to tooth discoloration risk 2, 1, 2, 1
- For children ≥8 years: 2 mg/lb (4 mg/kg/day) divided into 2 doses, maximum 100 mg per dose 3
Clinical Context and Positioning
Doxycycline is positioned as a second-line or alternative agent for skin and soft tissue infections, not a first-line choice. The 2014 IDSA guidelines classify it as having "limited recent clinical experience" and note it is bacteriostatic 1. However, it serves specific roles:
When to Consider Doxycycline
For MRSA coverage in purulent infections:
- Doxycycline is recommended alongside TMP-SMX, clindamycin, and linezolid for outpatient purulent SSTIs when MRSA is suspected 1, 4
- Recent data shows clinical failure rates as low as 6% for appropriate cases 5
For non-purulent infections (cellulitis):
- Doxycycline is not the preferred agent for typical streptococcal cellulitis
- First-line agents should target streptococci (beta-lactams like cephalexin or dicloxacillin) 1
- Consider doxycycline only when MRSA coverage is needed (penetrating trauma, known MRSA colonization, injection drug use) 1
Important Caveats
Resistance considerations:
- Doxycycline efficacy depends on local tetracycline resistance patterns 5, 6
- In areas with high tetracycline susceptibility (>95%), doxycycline shows comparable outcomes to other agents 6
- Always verify local antibiograms before prescribing
Comparative effectiveness:
- One study showed all clinical failures occurred in the TMP-SMX group versus doxycycline (though not statistically significant) 7
- Retrospective data suggests doxycycline/minocycline may be superior to beta-lactams for community-acquired MRSA SSTIs 6
- Recent propensity-matched analysis showed equivalent 6% failure rates between doxycycline and cephalexin for presumed streptococcal infections 5
Practical Algorithm
Step 1: Classify the infection
- Purulent (abscess, furuncle) → Consider doxycycline if MRSA suspected
- Non-purulent (cellulitis, erysipelas) → Beta-lactam preferred unless MRSA risk factors present
Step 2: Assess MRSA risk factors
- Recent hospitalization, injection drug use, known MRSA colonization, penetrating trauma → Add MRSA coverage
- No risk factors → Beta-lactam monotherapy adequate
Step 3: Verify local resistance
- Check if local MRSA tetracycline susceptibility >90%
- If high resistance, choose alternative (TMP-SMX, clindamycin, linezolid)
Step 4: Dosing
- 100 mg PO BID for 5-7 days minimum
- Extend to 10 days if slow response
- Reassess at 48-72 hours
Key Warnings
- Contraindicated in pregnancy 8
- Avoid in children <8 years (permanent tooth discoloration) 2, 1
- Take with adequate fluids to prevent esophageal irritation 3
- Can be taken with food/milk without affecting absorption 3
- Monitor for photosensitivity reactions
- Not appropriate for severe/complicated infections requiring IV therapy 1
Bottom line: While doxycycline 100 mg BID for 5-10 days is an acceptable option for outpatient SSTIs with MRSA coverage needs, it should not be your default choice for simple cellulitis where beta-lactams remain superior for streptococcal coverage. Reserve doxycycline for purulent infections or when specific MRSA risk factors are present and local susceptibility supports its use.